Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Central South University, Changsha, PR China.
The Clinical Center for Gene Diagnosis and Therapy of The State Key Laboratory of Medical Genetics, The Second Xiangya Hospital of Central South University, Central South University, Changsha, Hunan, PR China.
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211060202. doi: 10.1177/15330338211060202.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer affecting humans. However, appropriate biomarkers for diagnosis and prognosis have not yet been established. Here, we evaluated the gene expression profiles of patients with NSCLC to identify novel biomarkers. Three datasets were downloaded from the Gene Expression Omnibus (GEO) database, and differentially expressed genes were analyzed. Venn diagram software was applied to screen differentially expressed genes, and gene ontology functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed. Cytoscape was used to analyze protein-protein interactions (PPI) and Kaplan-Meier Plotter was used to evaluate the survival rates. Oncomine database, Gene Expression Profiling Interactive Analysis (GEPIA), and The Human Protein Atlas (THPA) were used to analyze protein expression. Quantitative real-time polymerase (qPCR) chain reaction was used to verify gene expression. We identified 595 differentially expressed genes shared by the three datasets. The PPI network of these differentially expressed genes had 202 nodes and 743 edges. Survival analysis identified 10 hub genes with the highest connectivity, 9 of which (, , , , , , , , and ) were related to poor overall survival in patients with NSCLC. In cell experiments, , , , and expression levels were upregulated, and among different types of NSCLC, these four genes showed highest expression in large cell lung cancer. The highest prognostic value was detected for patients who had successfully undergone surgery and for those who had not received chemotherapy. Notably, and showed good prognostic value for patients who had not received radiotherapy. : , , , and expression levels were upregulated in patients with NSCLC. These genes may be meaningful diagnostic biomarkers and could facilitate the development of targeted therapies.
非小细胞肺癌 (NSCLC) 是影响人类的最常见肺癌类型。然而,尚未建立用于诊断和预后的适当生物标志物。在这里,我们评估了 NSCLC 患者的基因表达谱,以鉴定新的生物标志物。从基因表达综合 (GEO) 数据库下载了三个数据集,并分析了差异表达基因。使用 Venn 图软件筛选差异表达基因,并进行基因本体论功能分析和京都基因与基因组百科全书 (KEGG) 通路分析。使用 Cytoscape 分析蛋白质-蛋白质相互作用 (PPI),使用 Kaplan-Meier Plotter 评估生存率。Oncomine 数据库、基因表达谱分析交互式分析 (GEPIA) 和人类蛋白质图谱 (THPA) 用于分析蛋白质表达。使用定量实时聚合酶 (qPCR) 链反应验证基因表达。我们确定了三个数据集共有的 595 个差异表达基因。这些差异表达基因的 PPI 网络有 202 个节点和 743 个边。生存分析确定了 10 个具有最高连通性的枢纽基因,其中 9 个(、、、、、、、和)与 NSCLC 患者总体生存率较差有关。在细胞实验中,、、、和的表达水平上调,并且在不同类型的 NSCLC 中,这四个基因在大细胞肺癌中表达最高。对于已成功接受手术和未接受化疗的患者,检测到最高的预后价值。值得注意的是,和对于未接受放疗的患者具有良好的预后价值。在 NSCLC 患者中,、、、和的表达水平上调。这些基因可能是有意义的诊断生物标志物,并有助于开发靶向治疗。